Tower Research Capital (TRC)’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Tower Research Capital (TRC)’s Portfolio UTRS Stock Details UTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-193	Closed	-$636	–	6391
2023 Q3	$636	Sell	193 -569	-75%	-$2.59K	﹤0.01%	5513
2023 Q2	$3.9K	Sell	762 -1,425	-65%	-$6.97K	﹤0.01%	5010
2023 Q1	$10K	Buy	+2,187	New	+$13.5K	﹤0.01%	4448
2022 Q1	–	Sell	-14	Closed	-$1K	–	6821
2021 Q4	$1K	Buy	+14	New	+$1.99K	﹤0.01%	5958

Tower Research Capital (TRC)'s UTRS Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q4 2023, closing a stake of 193 shares — an estimated $636 sold.

Tower Research Capital (TRC) first reported a position in UTRS in Q4 2021 and held it in 4 quarters. The position peaked at $10K in Q1 2023. 0 funds tracked by Wall St. Rank hold UTRS as of Q4 2023.

Tower Research Capital (TRC) reported no remaining Minerva Surgical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 193 Minerva Surgical, Inc. Common Stock shares in Q4 2023, an estimated $636.
Tower Research Capital (TRC) first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Tower Research Capital (TRC)'s Minerva Surgical, Inc. Common Stock position peaked at $10K in Q1 2023.
0 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.